New Key Statistics Module, Z-Score and F-Score
NAS:CNTA Key Ratios
| Market Cap $ M | 2,185.66 |
| Enterprise Value $ M | 1,940.48 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 6.77 |
| Price/Sales | 247.16 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 6.00 |
| EPS (TTM) $ | -1.55 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -13.14 |
| EV-to-EBITDA | -13.23 |
| PEG | -- |
| Shares Outstanding M | 128.57 |
| Net Margin (%) | -2,296.03 |
| Operating Margin % | -2,268.45 |
| Pre-tax Margin (%) | -2,303.27 |
| Quick Ratio | 13.29 |
| Current Ratio | 13.29 |
| ROA % (ttm) | -42.35 |
| ROE % (ttm) | -61.74 |
| ROIC % (ttm) | -232.43 |
| Dividend Yield % | -- |
| Altman Z-Score | 8.38 |
CNTA Number of Guru Trades
CNTA Volume of Guru Trades
Gurus Latest Trades with NAS:CNTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CNTA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Centessa Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:CNTA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers